177 related articles for article (PubMed ID: 25424249)
1. Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals.
Narita Y; Taniguchi H; Komori K; Kimura K; Kinoshita T; Komori A; Nomura M; Kadowaki S; Takahari D; Ura T; Andoh M; Muro K
Int J Clin Oncol; 2015 Aug; 20(4):755-60. PubMed ID: 25424249
[TBL] [Abstract][Full Text] [Related]
2. [A questionnaire survey on QOL and toxicity in colorectal cancer survivors who received adjuvant chemotherapy].
Taniguchi H; Narita Y; Komori K; Kimura K; Kinoshita T; Komori A; Uegaki S; Nomura M; Nitta S; Yamaguchi K; Kadowaki S; Takahari D; Ura T; Andoh M; Muro K
Gan To Kagaku Ryoho; 2015 Apr; 42(4):457-61. PubMed ID: 25963692
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?
Madbouly KM; Hussein AM; Zeid A
Dis Colon Rectum; 2013 May; 56(5):577-85. PubMed ID: 23575396
[TBL] [Abstract][Full Text] [Related]
5. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.
Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G
Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732
[TBL] [Abstract][Full Text] [Related]
6. [Tolerability of Oxaliplatin-Based Adjuvant Chemotherapy for Patients with Colorectal Cancer].
Matsuo H; Nakanishi M; Arita T; Murayama Y; Kuriu Y; Kosuga T; Konishi H; Morimura R; Komatsu S; Shiozaki A; Ikoma H; Ichikawa D; Fujiwara H; Okamoto K; Otsuji E
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2112-4. PubMed ID: 26805281
[TBL] [Abstract][Full Text] [Related]
7. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer.
Cercek A; Siegel CL; Capanu M; Reidy-Lagunes D; Saltz LB
Clin Colorectal Cancer; 2013 Sep; 12(3):163-7. PubMed ID: 23871161
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data.
Lin PC; Lee MY; Wang WS; Yen CC; Chao TC; Hsiao LT; Yang MH; Chen PM; Lin KP; Chiou TJ
Support Care Cancer; 2006 May; 14(5):484-7. PubMed ID: 16450089
[TBL] [Abstract][Full Text] [Related]
9. A Study on the Tolerability of Capecitabine plus Oxaliplatin as Adjuvant Chemotherapy.
Nakanishi M; Kuriu Y; Murayama Y; Arita T; Kosuga T; Morimura R; Konishi H; Komatsu S; Shiozaki A; Ikoma H; Ichikawa D; Fujiwara H; Okamoto K; Otsuji E
Anticancer Res; 2016 Apr; 36(4):1851-4. PubMed ID: 27069169
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors.
Tofthagen C; Donovan KA; Morgan MA; Shibata D; Yeh Y
Support Care Cancer; 2013 Dec; 21(12):3307-13. PubMed ID: 23903798
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
[TBL] [Abstract][Full Text] [Related]
12. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?
Simes RJ; Coates AS
J Natl Cancer Inst Monogr; 2001; (30):146-52. PubMed ID: 11773309
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer.
Angitapalli R; Litwin AM; Kumar PR; Nasser E; Lombardo J; Mashtare T; Wilding GE; Fakih MG
Oncology; 2009; 76(5):363-8. PubMed ID: 19321964
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.
Kim HR; Min BS; Kim JS; Shin SJ; Ahn JB; Rho JK; Kim NK; Rha SY
Oncology; 2011; 81(3-4):175-83. PubMed ID: 22057187
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.
Cohen SA; Wu C; Yu M; Gourgioti G; Wirtz R; Raptou G; Gkakou C; Kotoula V; Pentheroudakis G; Papaxoinis G; Karavasilis V; Pectasides D; Kalogeras KT; Fountzilas G; Grady WM
Clin Colorectal Cancer; 2016 Jun; 15(2):164-9. PubMed ID: 26702772
[TBL] [Abstract][Full Text] [Related]
17. Large Colorectal Carcinoma Is Predictive of Recurrence After Adjuvant Chemotherapy Using Oxaliplatin.
Nozawa H; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Watanabe T
Anticancer Res; 2015 Sep; 35(9):5073-8. PubMed ID: 26254409
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of interhospital variation in adjuvant chemotherapy for patients with Stage II/III colorectal cancer: a nationwide study.
Arakawa K; Kawai K; Tanaka T; Hata K; Sugihara K; Nozawa H
Colorectal Dis; 2018 Jul; 20(7):O162-O172. PubMed ID: 29752849
[TBL] [Abstract][Full Text] [Related]
19. Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer.
Leonard GD; Wright MA; Quinn MG; Fioravanti S; Harold N; Schuler B; Thomas RR; Grem JL
BMC Cancer; 2005 Sep; 5():116. PubMed ID: 16168057
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability in the management of stage II colorectal patients.
Strâmbu V; Garofil D; Pop F; Radu P; Brătucu M; Iorga C; Iorga R; Pasnicu C; Ion A; Popa F
Chirurgia (Bucur); 2013; 108(6):816-21. PubMed ID: 24331320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]